Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma

Jacob J. Mandel, Shlomit Yust-Katz, Akash J. Patel, David Cachia, DIane Liu, Minjeong Park, Ying Yuan, Thomas A. Kent, John F. De Groot*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences